Table 3.
Menstrual cycle status before the intervention
| Menstrual before | |||||
|---|---|---|---|---|---|
| Regular | Irregular | Total | |||
| group | placebo | Count | 3 | 35 | 38 |
| % within group | 7.9% | 92.1% | 100.0% | ||
| intervention | Count | 1 | 37 | 38 | |
| % within group | 2.6% | 97.4% | 100.0% | ||
| Total | Count | 4 | 72 | 76 | |
| % within group | 5.3% | 94.7% | 100.0% | ||
| Menstrual after | |||||
| group | placebo | Count | 5 | 33 | 38 |
| % within group | 13.2% | 86.8% | 100.0% | ||
| intervention | Count | 16 | 22 | 38 | |
| % within group | 42.1% | 57.9% | 100.0% | ||
| Total | Count | 21 | 55 | 76 | |
| % within group | 27.6% | 72.4% | 100.0% | ||
Group 1: placebo. Group 2: EPO 1000 mg/day. Chi-Square Tests. p value less than 5% was considered significant.